DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell

Update: 2024-11-05

Description

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell. Dr. Phan speaks with Dr. Jain about treatment options for neuroendocrine carcinoma.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Comments

In Channel

Current State of NETs, Successes, and Future Directions in Latin America

2025-09-0948:37

The Intersection of Compassion and Burnout in NETs

2025-08-1229:47

Promising Advances in NEC Research and Treatment

2025-05-2737:44

Understanding the COMPETE Study and Its Implications

2025-03-3134:19

Terapias para tumores neuroendocrinos en México

2025-02-2522:57

2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment - Recorded November 22nd, 2024

2025-01-1444:50

2024 Symposium Abstracts: New Research Using Biomarkers for Neuroendocrine Tumor Treatment - Recorded November 21st, 2024

2025-01-0731:23

2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors - Recorded November 20th, 2024

2024-12-3118:15

2024 Symposium: Bridging the Gap with Patient Advocacy Groups - Recorded November 23rd, 2024

2024-12-1145:06

American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management

2024-11-2730:10

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell

2024-11-0537:38

NET Regional Education Conference Jointly Provided by The University of Minnesota and The Mayo Clinic

2024-10-2927:37

Bridging the Gap: Patient Advocacy

2024-10-0139:42

Discussion of the NETTER-2 Trial

2024-09-2426:00

Bone Marrow Toxicity Associated with PRRT

2024-08-1324:32

Sequencing Of Therapies in Advanced NETs

2024-06-1246:31

NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS

2024-04-1921:33

NANETS Communications Committee 2024 Plans and Projects

2024-02-2613:01

NET Doctors Discuss Highlights from ASCO2024

2024-02-1619:04

Highlights from NANETS’ 2023 Multidisciplinary NET Medical Symposium, Recorded in Detroit Nov. 2023

2023-12-2923:34

00:00

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell

#box-pro-ellipsis-175999012947790{-webkit-line-clamp:2;}DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell